Table 3 Safety of intranasal oxytocin in the pilot clinical trial
Intranasal oxytocin | Placebo |
|---|---|
Irritability | Fatigue |
Irritability (moderate) | Depressed mood |
Nasal congestion/allergy symptoms (two individuals) | Cough |
Query absence seizures | Worsening tics |
Fatigue | Panic attack – adverse reaction to sensation of first intranasal spray administration (moderate) |
Headache | Â |
Leg shaking | Â |
Increased energy | Â |